Literature DB >> 11931423

Is the distance a patient lives from hospital a risk factor for death from tuberculosis in rural South Africa?

R D Barker1, M E Nthangeni, F J C Millard.   

Abstract

SETTING: Tuberculosis programmes that rely on district hospitals for diagnosis and initiation of treatment may disadvantage those living furthest away. We present an analysis of such a programme in rural South Africa to see whether those living furthest from the hospital were at greatest risk of dying from tuberculosis.
METHODS: All patients diagnosed and treated for tuberculosis in three health districts in 1997 and 1998 were included. An estimate of the distance each patient travelled to get to the hospital was obtained. The distances the patients travelled were categorised into four groups. The furthest distance patients could reasonably be expected to travel to get to their nearest hospital was estimated as 60 km. Outcomes of treatment were recorded using standard definitions. The mortality of patients in each of the four groups was compared.
RESULTS: Of 1187 patients started on treatment for tuberculosis in the hospitals, 877 (74%) were known to be alive at the end of treatment, whereas 158 (13%) had died. Distance travelled was a risk factor for death, but only amongst those travelling more than 60 km to get to the hospital (0-20 km: n = 313, odds ratio [OR] 1; >20-40 km: n = 436, OR 1.09, 95% confidence interval [CI] 0.71-1.67; >40-60 km: n = 205, OR 0.97, 95%CI 0.57-1.65; >60 km: n = 79, OR 2.87, 95%CI 1.59-5.17).
CONCLUSION: The mortality from tuberculosis was high, even amongst those living closest to the hospital, and did not rise significantly within 60 km. The situation may be different for the relatively small number of patients who come from further away. The distance travelled to hospital for initial diagnosis does not account for the relatively high mortality amongst tuberculosis patients in this area.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11931423

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

1.  Investigating urban-rural disparities in tuberculosis treatment outcome in England and Wales.

Authors:  I Abubakar; J P Crofts; D Gelb; A Story; N Andrews; J M Watson
Journal:  Epidemiol Infect       Date:  2007-03-15       Impact factor: 2.451

2.  Tuberculosis notifications, characteristics and treatment outcomes: urban vs. rural Solomon Islands, 2000-2011.

Authors:  N Itogo; P C Hill; K Bissell; A D Harries; K Viney; S Gounder
Journal:  Public Health Action       Date:  2014-06-21

3.  Using healthcare-seeking behaviour to estimate the number of Nipah outbreaks missed by hospital-based surveillance in Bangladesh.

Authors:  Sonia T Hegde; Henrik Salje; Hossain M S Sazzad; M Jahangir Hossain; Mahmudur Rahman; Peter Daszak; John D Klena; Stuart T Nichol; Stephen P Luby; Emily S Gurley
Journal:  Int J Epidemiol       Date:  2019-08-01       Impact factor: 7.196

4.  Profile and determinants of unsuccessful tuberculosis outcome in rural Nigeria: Implications for tuberculosis control.

Authors:  Kingsley N Ukwaja; Sarah N Oshi; Isaac Alobu; Daniel C Oshi
Journal:  World J Methodol       Date:  2016-03-26

5.  Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa.

Authors:  Denise Evans; Kathryn Schnippel; Caroline Govathson; Tembeka Sineke; Andrew Black; Lawrence Long; Rebecca Berhanu; Sydney Rosen
Journal:  PLoS One       Date:  2017-07-26       Impact factor: 3.240

6.  HIV infection modifies the relationship between distance to a health facility and treatment success rate for tuberculosis in rural eastern Uganda.

Authors:  Ben Olupot; Norbert Adrawa; Francis Bajunirwe; Jonathan Izudi
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-03-04

7.  Independent predictors of tuberculosis mortality in a high HIV prevalence setting: a retrospective cohort study.

Authors:  Dominique J Pepper; Michael Schomaker; Robert J Wilkinson; Virginia de Azevedo; Gary Maartens
Journal:  AIDS Res Ther       Date:  2015-10-06       Impact factor: 2.250

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.